Delix Therapeutics
Pre-clinicalDelix is revolutionizing brain health therapeutics with a novel class of neuroplasticity promoting compounds known as psychoplastogens or neuroplastogens
Founded
2019
Focus
Small MoleculesPsychedelics
About
Delix is revolutionizing brain health therapeutics with a novel class of neuroplasticity promoting compounds known as psychoplastogens or neuroplastogens
Funding History
2Total raised: $82M
Series A$70MRA Capital ManagementDec 15, 2021
Seed$12MArtis VenturesOct 15, 2020
Company Info
TypePrivate
Founded2019
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile